These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structural and cellular changes in canine myxomatous mitral valve disease: an image analysis study. Han RI; Black A; Culshaw G; French AT; Corcoran BM J Heart Valve Dis; 2010 Jan; 19(1):60-70. PubMed ID: 20329491 [TBL] [Abstract][Full Text] [Related]
3. Increased endothelin-receptor density in myxomatous canine mitral valve leaflets. Mow T; Pedersen HD J Cardiovasc Pharmacol; 1999 Aug; 34(2):254-60. PubMed ID: 10445677 [TBL] [Abstract][Full Text] [Related]
4. Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease. Han RI; Black A; Culshaw GJ; French AT; Else RW; Corcoran BM Am J Vet Res; 2008 Jun; 69(6):763-9. PubMed ID: 18518656 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration. Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis and abundance of Bcl-2 family and transforming growth factor β1 signaling proteins in canine myxomatous mitral valves. Surachetpong S; Jiranantasak T; Rungsipipat A; Orton EC J Vet Cardiol; 2013 Sep; 15(3):171-80. PubMed ID: 23816827 [TBL] [Abstract][Full Text] [Related]
7. Anatomic regurgitant orifice area obtained using 3D-echocardiography as an indicator of severity of mitral regurgitation in dogs with myxomatous mitral valve disease. Müller S; Menciotti G; Borgarelli M J Vet Cardiol; 2017 Oct; 19(5):433-440. PubMed ID: 28964709 [TBL] [Abstract][Full Text] [Related]
8. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease. Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933 [TBL] [Abstract][Full Text] [Related]
9. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease. Lu CC; Liu MM; Culshaw G; French A; Corcoran B J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643 [TBL] [Abstract][Full Text] [Related]
10. No expression of angiotensin II receptors and angiotensin-converting enzyme in myxomatous canine mitral valve leaflets. An autoradiographic study. Mow T; Pedersen HD Zentralbl Veterinarmed A; 1999 Oct; 46(8):465-72. PubMed ID: 10596285 [TBL] [Abstract][Full Text] [Related]
12. Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease. Dickson D; Caivano D; Matos JN; Summerfield N; Rishniw M J Vet Cardiol; 2017 Dec; 19(6):469-479. PubMed ID: 29111284 [TBL] [Abstract][Full Text] [Related]
13. Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease. Li Q; Larouche-Lebel É; Loughran KA; Huh TP; Suchodolski JS; Oyama MA J Am Heart Assoc; 2021 May; 10(9):e018923. PubMed ID: 33890477 [TBL] [Abstract][Full Text] [Related]
14. Distribution of NADPH-diaphorase and AChE activity in the anterior leaflet of rat mitral valve. Lovasova K; Kluchova D; Bolekova A; Dorko F; Spakovska T Eur J Histochem; 2010 Feb; 54(1):e5. PubMed ID: 20353912 [TBL] [Abstract][Full Text] [Related]
15. Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs. Li Q; Heaney A; Langenfeld-McCoy N; Boler BV; Laflamme DP BMC Vet Res; 2019 Nov; 15(1):425. PubMed ID: 31775756 [TBL] [Abstract][Full Text] [Related]
16. Echocardiographic evaluation of deformity and enlargement of the canine mitral valve annulus associated with myxomatous degenerative mitral valve disease. Mihara K; Kanemoto I; Sato K; Yasuhira Y; Watanabe I; Misumi K J Vet Cardiol; 2021 Oct; 37():8-17. PubMed ID: 34507141 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease. Hong HJ; Oh YI; Park SM; An JH; Kim TH; Chae HK; Seo KW; Youn HY BMC Vet Res; 2022 Jul; 18(1):261. PubMed ID: 35790968 [TBL] [Abstract][Full Text] [Related]